Skip to main content
Log in

Pegfilgrastim in primary prophylaxis of febrile neutropenia in elderly patients with hematological malignancies—bendamustine and G-CSF support

  • Letter to the Editor
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Imataki O, Uchida S, Yokokura S, Uemura M, Kadowaki N (2018) Bendamustine and G-CSF support. Support Care Cancer

  2. Cerchione C, De Renzo A, Di Perna M et al (2017) Pegfilgrastim in primary prophylaxis of febrile neutropenia following frontline bendamustine plus rituximab treatment in patients with indolent non-Hodgkin lymphoma: a single center, real-life experience. Support Care Cancer 25(3):839–845

    Article  PubMed  Google Scholar 

  3. Balducci L, Repetto L (2004) Increased risk of myelotoxicity in elderly patients with non-Hodgkin lymphoma. Cancer 100(1):6–11

    Article  Google Scholar 

  4. Sosa R, Li S, Molony JT, Liu J, Stryker S, Collins AJ (2017) Use of prophylactic growth factors and antimicrobials in elderly patients with cancer: a review of the Medicare database. Support Care Cancer 25(10):3123–3132

    Article  PubMed  Google Scholar 

  5. Mondello P, Steiner N, Willenbacher W, Cerchione C, Nappi D, Mauro E, Ferrero S, Cuzzocrea S, Mian M (2018) Bendamustine plus rituximab versus R-CHOP as first-line treatment for patients with follicular lymphoma grade 3A: evidence from a multicenter, retrospective study. Oncologist 23(4):454–460

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Cerchione C, Catalano L, Pareto AE et al (2017) Pegfilgrastim in primary prophylaxis of febrile neutropenia during chemotherapy of relapsed and refractory multiple myeloma: a real-life experience. Support Care Cancer 23(2):301–302

    Article  Google Scholar 

  7. Cerchione C, Catalano L, Peluso I, Nappi D, di Perna M, Salvatore D, Migliaccio I, Picardi M, Pane F (2016) Managing neutropenia by pegfilgrastim in patients affected by relapsed/refractory multiple myeloma treated with bendamustine-bortezomib-dexamethasone. Support Care Cancer 24(12):4835–4837

    Article  PubMed  PubMed Central  Google Scholar 

  8. Cerchione C, Nappi D, Di Perna M et al (2017) A case of efficacy of bendamustine in heavily pretreated multiple myeloma, refractory to pomalidomide. Clin Case Rep 5(4):505–507

    Article  PubMed  PubMed Central  Google Scholar 

  9. Cerchione C, Nappi D, Di Perna M et al (2016) Retreatment with bendamustine-bortezomib-dexamethasone in a patient with relapsed/refractory multiple myeloma. Case Rep Hematol 2016:6745286

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Claudio Cerchione.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cerchione, C., De Renzo, A., Nappi, D. et al. Pegfilgrastim in primary prophylaxis of febrile neutropenia in elderly patients with hematological malignancies—bendamustine and G-CSF support. Support Care Cancer 27, 1587–1588 (2019). https://doi.org/10.1007/s00520-019-4651-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-019-4651-5

Navigation